Related Experiment Videos
The selective vulnerability of nerve cells in Huntington's disease
1Institute of Clinical Neurosciences, Frenchay Hospital, Bristol and Clinical Neuroscience Research Group, Department of Medicine, University of Manchester, Manchester, UK. ksieradzan@aol.com
Neuropathology and Applied Neurobiology
|April 12, 2001
Summary
Huntington's disease (HD) involves toxic huntingtin protein fragments that aggregate and cause neurodegeneration. This study explores how these fragments impact specific brain cells, leading to selective neuronal death in HD.
Area of Science:
- Neuroscience
- Genetics
- Molecular Biology
Background:
- Huntington's disease (HD) is caused by a genetic mutation leading to an expanded polyglutamine (polyQ) tract in the huntingtin protein.
- This expansion results in toxic N-terminal fragments that aggregate and cause neurotoxicity, likely through apoptotic pathways.
- The exact mechanism of selective neuronal vulnerability in HD remains unclear.
Purpose of the Study:
- To investigate the molecular pathology underlying selective neurodegeneration in Huntington's disease.
- To explore the role of mutant huntingtin aggregation and nuclear accumulation in neuronal dysfunction.
- To elucidate the contribution of transcriptional interference and excitotoxicity to HD pathogenesis.
Main Methods:
- Experimental modeling in cultured neuronal and non-neuronal cells.
- Analysis of protein aggregates in human HD brain tissue.
- Investigation of nuclear huntingtin accumulation and its effects on gene transcription.
Main Results:
- Mutant huntingtin fragments aggregate and translocate to the nucleus, forming inclusions.
- Nuclear accumulation of mutant huntingtin interferes with transcriptional processes, particularly affecting neurotransmitter receptor genes.
- This interference may lead to chronic excitotoxicity, selectively damaging striatal projection neurons.
Conclusions:
- The selective vulnerability of neurons in HD is likely due to a combination of direct mutant huntingtin toxicity and secondary excitotoxicity.
- Nuclear accumulation of mutant huntingtin and subsequent transcriptional dysregulation are key events in HD pathogenesis.
- Understanding these mechanisms may offer targets for therapeutic interventions in HD and other polyglutamine disorders.